Connecting you to content on EBSCOhost

Works by Blaes, Jonas

Results: 6

1

Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway.

Published in:

Glia (0894-1491), 2015, v. 63, n. 1, p. 78, doi. 10.1002/glia.22734

By:

Ott, Martina;
Litzenburger, Ulrike M.;
Rauschenbach, Katharina J.;
Bunse, Lukas;
Ochs, Katharina;
Sahm, Felix;
Pusch, Stefan;
Opitz, Christiane A.;
Blaes, Jonas;
von Deimling, Andreas;
Wick, Wolfgang;
Platten, Michael

Publication type:

Article

2

Tweety-Homolog 1 Drives Brain Colonization of Gliomas.

Published in:

Journal of Neuroscience, 2017, v. 37, n. 29, p. 6837, doi. 10.1523/JNEUROSCI.3532-16.2017

By:

Jung, Erik;
Osswald, Matthias;
Blaes, Jonas;
Wiestler, Benedikt;
Sahm, Felix;
Schmenger, Torsten;
Solecki, Gergely;
Deumelandt, Katrin;
Kurz, Felix T.;
Ruifan Xie;
Weil, Sophie;
Heil, Oliver;
Thomé, Carina;
Gömmel, Miriam;
Syed, Mustafa;
Häring, Peter;
Huber, Peter E.;
Heiland, Sabine;
Platten, Michael;
von Deimling, Andreas

Publication type:

Article

3

HLA-DQA1*05 Associates With Anti-Tumor Necrosis Factor Immunogenicity and Low Adalimumab Trough Concentrations in Inflammatory Bowel Disease Patients From the SERENE Ulcerative Colitis and Crohn's Disease Studies.

Published in:

Journal of Crohn's & Colitis, 2025, v. 19, p. 1, doi. 10.1093/ecco-jcc/jjae129

By:

Reppell, Mark;
Zheng, Xiuwen;
Dreher, Ingeborg;
Blaes, Jonas;
Regan, Elina;
Haslberger, Tobias;
Guay, Heath;
Pivorunas, Valerie;
Smaoui, Nizar

Publication type:

Article

4

A first‐in‐human study of the novel immunology antibody–drug conjugate, ABBV‐3373, in healthy participants.

Published in:

British Journal of Clinical Pharmacology, 2024, v. 90, n. 1, p. 189, doi. 10.1111/bcp.15888

By:

D'Cunha, Ronilda;
Kupper, Hartmut;
Arikan, Dilek;
Zhao, Weihan;
Carter, David;
Blaes, Jonas;
Ruzek, Melanie;
Pang, Yinuo

Publication type:

Article

5

Assessing the Impact of Immunogenicity and Improving Prediction of Trough Concentrations: Population Pharmacokinetic Modeling of Adalimumab in Patients with Crohn's Disease and Ulcerative Colitis.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 623, doi. 10.1007/s40262-023-01221-x

By:

Ponce-Bobadilla, Ana Victoria;
Stodtmann, Sven;
Chen, Mong-Jen;
Winzenborg, Insa;
Mensing, Sven;
Blaes, Jonas;
Haslberger, Tobias;
Laplanche, Loic;
Dreher, Ingeborg;
Mostafa, Nael M.

Publication type:

Article

6

Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?

Published in:

Journal of Neurochemistry, 2014, v. 131, n. 2, p. 251, doi. 10.1111/jnc.12802

By:

Lemke, Dieter;
Weiler, Markus;
Blaes, Jonas;
Wiestler, Benedikt;
Jestaedt, Leonie;
Klein, Ann‐Catherine;
Löw, Sarah;
Eisele, Günter;
Radlwimmer, Bernhard;
Capper, David;
Schmieder, Kirsten;
Mittelbronn, Michel;
Combs, Stephanie E.;
Bendszus, Martin;
Weller, Michael;
Platten, Michael;
Wick, Wolfgang

Publication type:

Article